Literature DB >> 13200

Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.

R Nickander, S E Smits, M I Steinberg.   

Abstract

alpha-d-Propoxyphene and its principle metabolite, alpha-d-norpropoxyphene, were compared pharmacologically to establish their relative opioid profiles as defined by naloxone reversal. Propoxyphene exhibited opioid activity in the following tests: mouse abdominal constriction and rat tail heat analgesic tests, inhibition of the twitch of the guinea-pig ileum and acute lethality in rodents. Norpropoxyphene also showed opioid activity in the rat tail heat and guinea-pig ileum tests, but exhibited nonopioid activity in the mouse abdominal constriction and acute toxicity studies. Jumping in mice, precipitated by naloxone, suggests the following order for liability to produce physical dependence after repeated administration: morphine greater than codeine greater than propoxyphene greater than norpropoxyphene approximately saline. Propoxyphene and norpropoxyphene depressed axonal conduction in isolated peripheral nerve and were comparable in potency to standard local anesthetic agents. The nonopioid actions of norpropoxyphene might be due in part to its local anesthetic properties.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13200

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Pharmacokinetics of opioids in renal dysfunction.

Authors:  G Davies; C Kingswood; M Street
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 2.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

3.  Failure of naloxone to reverse the cardiotoxocity of Distalgesic overdose.

Authors:  C J Barraclough; R A Lowe
Journal:  Postgrad Med J       Date:  1982-10       Impact factor: 2.401

Review 4.  Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.

Authors:  A A Lawson; D B Northridge
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

5.  Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.

Authors:  D C Whitcomb; F R Gilliam; C F Starmer; A O Grant
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Dextropropoxyphene kinetics after single and repeated oral doses in man.

Authors:  K Brøsen; L F Gram; J Schou; N E Larsen; P Thayssen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male Wistar rats.

Authors:  E Bodd; H Olsen; M Gulliksen; J Mørland
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

Review 8.  Dextropropoxyphene overdosage. Pharmacological considerations and clinical management.

Authors:  R J Young
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

9.  Methadone block of K+ current in squid giant fiber lobe neurons.

Authors:  F T Horrigan; W F Gilly
Journal:  J Gen Physiol       Date:  1996-02       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.